- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04076215
Biochemical and Physiological Response to Stressogenic Stimuli
Measuring the Biochemical and Physiological Response to Controlled Stressogenic Stimuli
Post-traumatic stress disorder (PTSD) is characterized by physiological changes, some of which are thought to be chronic, while others are observed in response to stressogenic stimuli. A psychiatric diagnosis of PTSD is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. Discernable patterns of stress-related measures may constitute a physiological and biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans.
The current study is aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD. Physiological and biochemical data will be collected from participants with and without PTSD using wearable sensors and adhesive biosensor patches. The data will be collected in two conditions: in a neutral, quiet situation, and during and following exposure to controlled stressogenic stimuli.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PTSD diagnosis (excluding controls)
- Proper ability to give informed consent
Exclusion Criteria:
- Active oncological/cardiovascular condition
- Dialysis patients
- Active psychotic or suicidal symptoms
- Severe dissociative symptoms
- A traumatic brain injury (TBI) diagnosis
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pariticapnts with PTSD
|
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.
|
Experimental: Pariticapnts without PTSD (controls)
|
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Significant differences between groups - HRV
Time Frame: 3 hours
|
Significant differences in Heart Rate Variability - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups - temperature
Time Frame: 3 hours
|
Significant differences in physiological changes - body temperature- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups - SPO2
Time Frame: 3 hours
|
Significant differences in physiological changes - Saturation SPO2- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups - blood pressure
Time Frame: 3 hours
|
Significant differences in physiological changes - continuous blood pressure- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups - pulse pressure
Time Frame: 3 hours
|
Significant differences in physiological changes - pulse pressure - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups -respiratory rate
Time Frame: 3 hours
|
Significant differences in physiological changes - respiratory rate- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups -stroke volume
Time Frame: 3 hours
|
Significant differences in physiological changes - stroke volume- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups -cardiac output
Time Frame: 3 hours
|
Significant differences in physiological changes - cardiac output - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in physiological changes between groups - systemic vascular resistance
Time Frame: 3 hours
|
Significant differences in physiological changes - systemic vascular resistance- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in cortisol levels between groups
Time Frame: 3 hours
|
Significant differences in biochemical changes - cortisol - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - C-reactive protein
Time Frame: 3 hours
|
Significant differences in biochemical changes - C-reactive protein - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - Interleukin 6
Time Frame: 3 hours
|
Significant differences in biochemical changes - Interleukin 6 - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - N-terminal B-type natriuretic peptide
Time Frame: 3 hours
|
Significant differences in biochemical changes - N-terminal B-type natriuretic peptide - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - 8-oxo-7
Time Frame: 3 hours
|
Significant differences in biochemical changes - 8-oxo-7- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - 8-dihydro-2'-deoxyguanosine
Time Frame: 3 hours
|
Significant differences in biochemical changes - 8-dihydro-2'-deoxyguanosine - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - hexanone
Time Frame: 3 hours
|
Significant differences in biochemical changes - hexanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - acetic acid
Time Frame: 3 hours
|
Significant differences in biochemical changes - acetic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - heptane
Time Frame: 3 hours
|
Significant differences in biochemical changes - heptane - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - hexanal
Time Frame: 3 hours
|
Significant differences in biochemical changes -hexanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - 3-heptanone
Time Frame: 3 hours
|
Significant differences in biochemical changes - 3-heptanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - hexanoic acid
Time Frame: 3 hours
|
Significant differences in biochemical changes - hexanoic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - heptanal
Time Frame: 3 hours
|
Significant differences in biochemical changes -heptanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - nonanal
Time Frame: 3 hours
|
Significant differences in biochemical changes - nonanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Significant differences in biochemical changes between groups - glucose
Time Frame: 3 hours
|
Significant differences in biochemical changes - glucose - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli
|
3 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6263-19-SMC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University of ZurichCompletedPost Traumatic Stress Disorder (PTSD) | Complex Post-Traumatic Stress Disorder (CPTSD)Switzerland
-
University of NottinghamNottinghamshire Healthcare NHS Trust; Lincolnshire Partnership NHS Foundation...CompletedDomestic Violence | Trauma, Psychological | Post-Traumatic Stress Disorder in Children | Narrative Exposure Therapy | Post-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder ComplexUnited Kingdom
-
Praxis Precision MedicinesTerminatedStress Disorders, Post-Traumatic | Trauma and Stressor Related Disorders | Post Traumatic Stress Disorder | Stress Disorder | Post-traumatic Stress Disorder | Mental DisorderUnited States
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
-
Direction Centrale du Service de Santé des ArméesRecruitingPost-traumatic Stress DisorderFrance
Clinical Trials on Stressogenic stimulus
-
University GhentCompleted
-
Akdeniz UniversityNot yet recruitingNursing Caries | Head Trauma | Traumatic Coma
-
University of SalamancaNot yet recruiting
-
Vrije Universiteit BrusselCompleted
-
Fondation Ophtalmologique Adolphe de RothschildTerminated
-
University of Alabama at BirminghamCompleted
-
Mount St. Mary's College, Los Angeles, CAUnknown
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompleted
-
Women and Infants Hospital of Rhode IslandCompletedOveractive Bladder